Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Holston Valley Medical Center is the first hospital in East Tennessee, Southwest Virginia and Southeast Kentucky to offer ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. The condition is more common in women and younger patients ...

An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...

Valvular heart disease (VHD) is a potentially fatal condition, yet it's difficult to diagnose with a regular stethoscope. A ...

Efimov said: “We could incorporate our pacemakers into other medical devices like heart valve replacements, which can cause ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage ... narrowing of ...

FRIDLEY, Minn. (AP) — Five miles may be all that separates Twin Cities-based St. Jude Medical and Medtronic, but competition between the two heart valve manufacturers has reached a global scale. The ...

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors. Its total funding is more than $200 million. Cardiac ...